Lung Neoplasm
generalA benign or malignant, primary or metastatic neoplasm involving the lungs. Representative examples of benign neoplasms include adenoma, papilloma, chondroma, and endobronchial lipoma. Representative examples of malignant neoplasms include carcinoma, carcinoid tumor, sarcoma, and lymphoma.
35
Centers
24
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Malignant Neoplasm of Lung | 7 |
Top Centers for Lung Neoplasm(35)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 72.0 |
| 2 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center | 72.0 |
| 3 | Princess Margaret Cancer CentreToronto, ON High-Volume Research Center | 72.0 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 61.7 |
| 5 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 61.7 |
| 6 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 61.7 |
| 7 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 61.7 |
| 8 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 61.7 |
| 9 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 61.7 |
| 10 | NCI Clinical Active Research Program | 61.7 |
| 11 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 61.7 |
| 12 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 61.7 |
| 13 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 61.7 |
| 14 | Boston University Cancer CenterBoston, MA Active Research Program | 61.7 |
| 15 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 61.7 |
| 16 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 61.7 |
| 17 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | 41.1 |
| 18 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 41.1 |
| 19 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 41.1 |
| 20 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 41.1 |
| 21 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 41.1 |
| 22 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 41.1 |
| 23 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 41.1 |
| 24 | Cleveland Clinic Cancer CenterCleveland, OH | 41.1 |
| 25 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 41.1 |
| 26 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 41.1 |
| 27 | University of Illinois Cancer CenterChicago, IL | 41.1 |
| 28 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 41.1 |
| 29 | Cancer Center at IllinoisUrbana, IL | 41.1 |
| 30 | Penn State Cancer InstituteHershey, PA | 41.1 |
| 31 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 41.1 |
| 32 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 41.1 |
| 33 | Upstate Cancer CenterSyracuse, NY | 41.1 |
| 34 | University of Texas Medical Branch Cancer CenterGalveston, TX | 41.1 |
| 35 | Louisiana Cancer Research CenterNew Orleans, LA | 41.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →